Agoracom Blog

AGORACOM Small Cap 60: Innocan $ #CBD Products Ready For Launch With Positive Clinical Test Results $ TLRY $ $APHA $ $

Posted by AGORACOM-JC at 2:33 PM on Monday, November 30th, 2020

Innocan (INNO:CSE) has 3 fully operating divisions to address the market for Cannabis products.  As a Cannabis investor, why limit yourself to a Company with just one specialty, when Innocan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products.

Tags: , , , , , , , ,

Comments are closed.